Filing Details

Accession Number:
0001140361-12-008349
Form Type:
5
Zero Holdings:
No
Publication Time:
2012-02-14 17:16:15
Reporting Period:
2011-12-31
Filing Date:
2012-02-14
Accepted Time:
2012-02-14 17:16:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221599 Steve Aselage C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-31 201 $13.23 46,679 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the issuer's Employee Stock Purchase Program ("ESPP"), for the ESPP purchase period of May 1, 2011 to October 31, 2011.